First Time Loading...

Zosano Pharma Corp
NASDAQ:ZSAN

Watchlist Manager
Zosano Pharma Corp Logo
Zosano Pharma Corp
NASDAQ:ZSAN
Watchlist
Price: 1 USD -43.18% Market Closed
Updated: May 6, 2024

Zosano Pharma Corp
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zosano Pharma Corp
Net Income (Common) Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Zosano Pharma Corp
NASDAQ:ZSAN
Net Income (Common)
-$55.2m
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Net Income (Common)
$1.2B
CAGR 3-Years
-7%
CAGR 5-Years
6%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$1.8B
CAGR 3-Years
106%
CAGR 5-Years
0%
CAGR 10-Years
17%
Stryker Corp
NYSE:SYK
Net Income (Common)
$3.4B
CAGR 3-Years
34%
CAGR 5-Years
-1%
CAGR 10-Years
16%
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$5.6B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2B
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
14%

See Also

What is Zosano Pharma Corp's Net Income (Common)?
Net Income (Common)
-55.2m USD

Based on the financial report for Mar 31, 2022, Zosano Pharma Corp's Net Income (Common) amounts to -55.2m USD.

What is Zosano Pharma Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-14%

Over the last year, the Net Income (Common) growth was -68%. The average annual Net Income (Common) growth rates for Zosano Pharma Corp have been -15% over the past three years , -14% over the past five years .